T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA

T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA was reported 20 times

T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 1 0.0017
1 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
2 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
3 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
4 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
5 Janus Kinase Inhibitor [EPC] 3 0.0000
6 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
7 BCL-2 Inhibitor [EPC] 1 0.0000
8 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
9 Purine Antimetabolite [EPC] 1 0.0000
10 5-alpha Reductase Inhibitor [EPC] 1 0.0000
11 Expectorant [EPC] 2 0.0000
12 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
13 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
15 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
16 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
18 Alkylating Drug [EPC] 1 0.0000
19 Kinase Inhibitor [EPC] 2 0.0000
20 Vitamin D [EPC] 1 0.0000
21 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
22 Vitamin B12 [EPC] 1 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
24 Vitamin C [EPC] 1 0.0000
25 Corticosteroid [EPC] 3 0.0000
26 Insulin Analog [EPC] 1 0.0000
27 Thalidomide Analog [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000